Literature DB >> 22269953

Endoscopic management of hilar cholangiocarcinoma.

Andrea Parodi1, Deborah Fisher, Marc Giovannini, Todd Baron, Massimo Conio.   

Abstract

Hilar cholangiocarcinoma has a poor prognosis and surgery remains the only curative option. However, few patients are diagnosed at a curable stage and palliative therapies are, therefore, mandatory. Endoscopy could have a useful role in the work-up of patients with hilar cholangiocarcinoma who are unsuitable for surgery. Endoscopic retrograde cholangiopancreatography provides an opportunity to collect specimens for cytological or histological diagnosis, yet is often nondiagnostic. Other techniques, including fluorescence in situ hybridization, confocal laser endomicroscopy and endoscopic ultrasonography, are now improving the accuracy of tissue diagnosis. This Review presents an overview of the diagnostic and therapeutic role of endoscopic procedures in the management of hilar cholangiocarcinoma. The use of such procedures in guiding the therapeutic management of patients with hilar cholangiocarcinoma is discussed, and the relative success of endoscopic stenting as the main palliative therapy for obstructive jaundice (a common complication of hilar cholangiocarcinoma) is described. The potential role of photodynamic therapy as a palliative treatment for patients with hilar cholangiocarcinoma is also outlined.

Entities:  

Mesh:

Year:  2012        PMID: 22269953     DOI: 10.1038/nrgastro.2011.271

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  75 in total

Review 1.  Early detection and treatment of cholangiocarcinoma.

Authors:  G J Gores
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

2.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Endoscopic deployment of multiple JOSTENT SelfX is effective and safe in treatment of malignant hilar biliary strictures.

Authors:  Hirofumi Kawamoto; Koichiro Tsutsumi; Ryo Harada; Masakuni Fujii; Hironari Kato; Ken Hirao; Naoko Kurihara; Takashi Nakanishi; Osamu Mizuno; Etsuji Ishida; Tsuneyoshi Ogawa; Hirotoshi Fukatsu; Kohsaku Sakaguchi
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03-07       Impact factor: 11.382

4.  Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.

Authors:  A A Polydorou; S R Cairns; J F Dowsett; A R Hatfield; P R Salmon; P B Cotton; R C Russell
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

5.  Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.

Authors:  J J W Tischendorf; M Krüger; C Trautwein; N Duckstein; A Schneider; M P Manns; P N Meier
Journal:  Endoscopy       Date:  2006-04-27       Impact factor: 10.093

6.  Contrast-free air cholangiography-assisted unilateral plastic stenting in malignant hilar biliary obstruction.

Authors:  Virendra Singh; Gurpreet Singh; Vikas Gupta; Rajesh Gupta; Rakesh Kapoor
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2010-02

7.  Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography.

Authors:  S Stavropoulos; A Larghi; E Verna; P Battezzati; P Stevens
Journal:  Endoscopy       Date:  2005-08       Impact factor: 10.093

8.  Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents.

Authors:  John L S Cheng; Marco J Bruno; Jacques J Bergman; Erik A Rauws; Guido N Tytgat; Kees Huibregtse
Journal:  Gastrointest Endosc       Date:  2002-07       Impact factor: 9.427

9.  Treatment of hilar carcinoma by bile drainage combined with internal radiotherapy using 192iridium wire.

Authors:  M S Fletcher; D Brinkley; J L Dawson; H Nunnerley; R Williams
Journal:  Br J Surg       Date:  1983-12       Impact factor: 6.939

10.  Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds".

Authors:  Nigel J Walker; Patrick W Crockett; Abraham Nyska; Amy E Brix; Michael P Jokinen; Donald M Sells; James R Hailey; Micheal Easterling; Joseph K Haseman; Ming Yin; Michael E Wyde; John R Bucher; Christopher J Portier
Journal:  Environ Health Perspect       Date:  2005-01       Impact factor: 9.031

View more
  3 in total

1.  TROP2 correlates with microvessel density and poor prognosis in hilar cholangiocarcinoma.

Authors:  Shanglei Ning; Sen Guo; Jianjun Xie; Yunfei Xu; Xiaofei Lu; Yuxin Chen
Journal:  J Gastrointest Surg       Date:  2012-12-01       Impact factor: 3.452

Review 2.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

Review 3.  Endoscopic drainage in patients with inoperable hilar cholangiocarcinoma.

Authors:  Ye Jin Park; Dae Hwan Kang
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.